Trump without side effects after two-week course of anti-malaria drug, White House doctor says

U.S. President Donald Trump had no side effects from a two-week course of hydroxychloroquine, an anti-malaria drug that can cause heart problems, after using it as a preventive measure against the coronavirus, his White House physician said on Wednesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

Hydroxychloroquine and lopinavir/ritonavir not found to help patients in hospitalCoronavirus – latest updatesSee all our coronavirus coverageThe World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drughydroxychloroquine and combination HIV drug lopinavir/ritonavir for patients in hospital with Covid-19 after they failed to reduce mortality.The setback came as WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day. The US accounted for 53,213 of the total 212,326 new cases recorded on Friday, the WHO said.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Medical research World Health Organization World news US news Pharmaceuticals industry Science Infectious diseases Source Type: news
The bio-detection dogs are already trained to detect odours of cancers, malaria and Parkinson's disease.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post How Deforestation Helps Deadly Viruses Jump from Animals to Humans appeared first on Inter Press Service.
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Environment Global Headlines Health TerraViva United Nations Source Type: news
Malaria remains a major global health burden, killing hundreds of thousands annually, especially in sub-Saharan Africa. In 2019, a Phase IV Expanded Programme on Immunization (EPI)-linked malaria vaccine implementation was underway. However, in December 2019, a novel pneumonia condition termed coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with many clinical, epidemiological, and biological parallels to malaria, was reported in Wuhan, China. COVID-19 is spreading rapidly, and, as of the 3rd of June, 2020, more than 382,507 persons had died from COVID-19. Childre...
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
Some villagers in the eastern Amazon are spurning Brazilian government advice to take the malaria drug hydroxychloroquine to keep the novel coronavirus at bay and are drinking tea of jamb ú, also known as the toothache plant.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalized patients. Results were announced Tuesday and researchers said they would publish them soon. The study is a large, strict test that randomly assigned 2,104 patients to get the drug and compared them with 4,321 patients getting only usual care. The drug was given either orally or through an IV. It reduced deaths by 35% in patients who needed treatment with breathing machines and by 20% in those only needing supplemental oxygen. It did ...
Source: TIME: Science - Category: Science Authors: Tags: Uncategorized Source Type: news
(Natural News) In an apparent act of spite against President Donald Trump, the U.S. Food and Drug Administration (FDA) has withdrawn emergency approval for hydroxychloroquine, the generic anti-malaria drug that many doctors have been prescribing to patients with the Wuhan coronavirus (COVID-19). Citing alleged safety and effectiveness concerns, the FDA revoked authorizations for both hydroxychloroquine...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
Food and Drug Administration says drug is unlikely to work against coronavirus and notes heart risksCoronavirus – latest updatesUS regulators revoked the emergency authorization for malaria drugs championed by Donald Trump for treating Covid-19, amidgrowing evidence they don ’t work and could cause serious side effects.The Food and Drug Administration (FDA) said on Monday the drugs hydroxychloroquine and chloroquine were unlikely to be effective in treating the coronavirus. Citing reports of heart complications, the agency said the drugs ’ unproven benefits “do not outweigh the known and potential r...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak US news Health US healthcare Society Science Infectious diseases Medical research World news Source Type: news
The agency said that a review of some studies showed that the drugs ’ potential benefits in treating Covid-19 did not outweigh the risks.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Drugs (Pharmaceuticals) Hydroxychloroquine (Drug) Coronavirus (2019-nCoV) Food and Drug Administration Biomedical Advanced Research and Development Authority Trump, Donald J Tests (Medical) Clinical Trials your-feed-healthcare Source Type: news
President Donald Trump said on Monday other countries had provided great reports on the effectiveness of malaria drug hydroxychloroquine for treatment of the deadly coronavirus, complaining that only U.S. agencies have failed to grasp its benefit.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: American Health | Cardiology | Coronavirus | COVID-19 | Health | Heart | Hydroxychloroquine | Malaria | Trump | USA Health